You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Portable Phage Preparation Technology for Field Application
SBC: CFD RESEARCH CORPORATION Topic: A20BT023Bacteriophages (phages) are becoming important therapeutic candidates against multidrug resistant (MDR) bacterial infections. There is a need to isolate and concentrate phages collected from the field to enhance specimen storage stability for long-distance transport to specialized laboratories for subsequent analysis. Environmental phage preparation requires expensive, bulky instrumentation and in ...
STTR Phase II 2023 Department of DefenseDefense Health Agency -
Flexible Microfluidic Process Technology for Biopharmaceutical Purification of Bacteriophages
SBC: CFD RESEARCH CORPORATION Topic: DHA21C002Multidrug resistant (MDR) bacterial wound infections remain a persistent challenge for front-line military medical providers in prolonged care treatment. Bacteriophage (phage) therapeutics have demonstrated preclinical and clinical efficacy against ESKAPEE infections. Phage production however remains a challenge to remove common pyrogen contaminants from phage products, including endotoxins (lipop ...
STTR Phase II 2023 Department of DefenseDefense Health Agency -
Flexible Microfluidic Process Technology for Biopharmaceutical Purification of Bacteriophages
SBC: CFD RESEARCH CORPORATION Topic: DHA21C002Multidrug resistant (MDR) bacterial wound infections remain a persistent challenge for front-line military medical providers in prolonged care treatment. Phage therapeutics have demonstrated preclinical and clinical efficacy against ESKAPEE infections. Phage production however remains a challenge to remove bacterial remnants including LPS endotoxins and other pyrogens. To meet regulatory requireme ...
STTR Phase I 2022 Department of DefenseDefense Health Agency -
Develop and demonstrate a technology for isolation of bacteriophages with enhanced antibiofilm activity
SBC: CFD RESEARCH CORPORATION Topic: DHA20B003The twenty-first century has seen a global rise in bacterial infections exhibiting antimicrobial-resistance (AMR). More than ninety percent of chronic wounds contain microbial biofilms that exhibit AMR, and the bacteria responsible for several of these recalcitrant infections are called ESKAPEE pathogens. Eradicating ESKAPEE pathogenic infections is challenging, but bacteriophage (phage) therapy i ...
STTR Phase II 2022 Department of DefenseDefense Health Agency -
ECCCHO: Effective Combat Casualty Care Handoff Operations
SBC: TIER 1 PERFORMANCE SOLUTIONS LLC Topic: DHA17B002According to the Joint Commission, approximately 70% of sentinel events in medical care are related to communication mishaps, and despite regular and frequent occurrence, poor communication during patient handoffs (i.e., transfer of patient care information, responsibility, and authority from one provider to another) remains a major contributor to medical errors (Nether, 2017; The Joint Commission ...
STTR Phase II 2021 Department of DefenseDefense Health Agency -
Inspire- In-Mask Sensors for Physiological Investigation of Respiratory Exhalation
SBC: MAKEL ENGINEERING, INC. Topic: DHP16C002High concentrations of supplemental oxygen are used routinely by pilots and divers prior to and during missions to prevent and treat decompression sickness, avoid detection during covert operations, and to support oxygenation following pulmonary injury. Due to pulmonary oxygen toxicity (PO2T), exposure limits are imposed to prevent damage to pulmonary tissues. Current policy focuses on preventing ...
STTR Phase II 2021 Department of DefenseDefense Health Agency -
CORE-Military: A Virtual Reality Platform for Emergency Care Training and Assessment in Austere Environments
SBC: Radiant Images Inc. Topic: DHA20B001In emergency medicine, time is a critical factor that can significantly influence the survival of seriously ill patients. Early recognition of clinical deterioration and rapid initial management is paramount in any setting where emergency care is provided. In military medicine and humanitarian care, delivering high quality and timely care to injured patients poses even greater and more complex cha ...
STTR Phase I 2021 Department of DefenseDefense Health Agency -
In-Ear Exposure Sensor with Integrated Noise Attenuation and Communications Capabilities
SBC: Diversified Technical Systems, Inc. Topic: DHA20B002According to the Department of Defense, there were more than 400,000 known TBI diagnoses in service members between 2000 and 2019 (DVBIC, 2020). Detection and measurement of potential injury due to blast overpressure and blunt impact have been priorities of the US military for many years, especially since Operation Enduring Freedom (OEF). Among those deployed, estimated rates of probable TBI range ...
STTR Phase I 2021 Department of DefenseDefense Health Agency -
A Microfluidic Impedance-Based Bacteriophage Capture and Antibiofilm Analyzer
SBC: CFD RESEARCH CORPORATION Topic: DHA20B003The twenty-first century has seen a global rise in bacterial infections exhibiting antimicrobial-resistance (AMR). More than ninety percent of chronic wounds contain microbial biofilms that exhibit AMR, and the bacteria responsible for several of these recalcitrant infections are called ESKAPEE pathogens. Eradicating ESKAPEE pathogenic infections is challenging, but bacteriophage (phage) therapy i ...
STTR Phase I 2021 Department of DefenseDefense Health Agency -
Eye-readable Solution-based Dye Displacement Probe for Large-area Detection of Opioids
SBC: INTELLIGENT OPTICAL SYSTEMS, INC. Topic: CBD20AT001Intelligent Optical Systems, Inc., in collaboration with Bowling Green State University, proposes to develop a field-rugged, eye-readable indicating spray solution that can immediately detect synthetic opioids over a large area of contamination (i.e., military vehicles, individual protective equipment, clandestine labs, etc.). The proposed chemosensor in a spray solution format will detect multipl ...
STTR Phase I 2021 Department of DefenseOffice for Chemical and Biological Defense